Several studies suggested that serum levels of a certain adipokine, apelin, were increased in endometrial cancer patients with high BMIs compared to those with normal BMIs [48], and apelin was upregulated in tumor tissues of HGSOC patients with high BMIs [48]. This evidence concerns the gene APLN and endometrial cancer.